Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$7.54 - $9.79 $738,166 - $958,440
-97,900 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$2.43 - $5.42 $22,484 - $50,151
-9,253 Reduced 8.64%
97,900 $473,000
Q2 2020

Aug 12, 2020

BUY
$1.33 - $3.63 $28,665 - $78,237
21,553 Added 25.18%
107,153 $332,000
Q4 2019

Jan 27, 2020

BUY
$1.3 - $2.72 $10,920 - $22,848
8,400 Added 10.88%
85,600 $174,000
Q4 2018

Feb 08, 2019

SELL
$2.24 - $3.9 $25,932 - $45,150
-11,577 Reduced 13.04%
77,200 $198,000
Q2 2018

Aug 15, 2018

BUY
$4.43 - $5.14 $51,286 - $59,505
11,577 Added 15.0%
88,777 $423,000
Q3 2017

Nov 15, 2017

BUY
$4.35 - $5.25 $335,820 - $405,300
77,200
77,200 $405,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.